The federal judiciary delivered a clear rebuke when U.S. District Judge Mustafa T. Kasubhai issued a final judgment dated April 18 that invalidated a policy promulgated by Health and Human Services Secretary Robert F. Kennedy Jr.. The decision set aside the so-called “Kennedy Declaration”, concluding that the administration had gone beyond its statutory powers in attempting to declare that gender-affirming care for minors was not safe or effective. By vacating that declaration, the court stopped its enforcement in the states that challenged the action, returning matters to the status quo for providers and families in those jurisdictions.
The ruling emphasized statutory and procedural limits on agency action: the court found that the declaration flouted required rulemaking under the Administrative Procedure Act and improperly sought to alter clinical standards that are governed by medical professionals and state regulators. The opinion underscored that federal programs such as Medicare and Medicaid cannot be wielded to unilaterally redefine the practice of medicine or to penalize clinicians for delivering care consistent with widely accepted guidelines. The decision framed these points as central to preserving the separation between policymaking and medical practice.
What the court said about process and authority
Judge Kasubhai’s opinion focused on the legality of how the policy was made rather than simply its content. He criticized the abrupt issuance of the declaration and found that federal officials did not follow the notice-and-comment procedures that the Administrative Procedure Act requires before adopting rules that impose consequences on third parties. The court also determined that the administration lacked the statutory authority to set nationwide treatment standards for minors or to exclude providers from federal programs for following recognized clinical guidance. As part of his relief, the judge permanently enjoined the government from enforcing the declaration in the plaintiff states and ordered agencies to notify officials within seven days that enforcement would cease.
Procedural failings and legal limits
At the heart of the dispute was a directive issued in December 2026 in which the department declared that gender-affirming care for young people was outside acceptable clinical practice and warned of funding consequences. That declaration formed part of a broader drive by the administration, including proposals voiced by other federal officials, to strip federal funding from institutions offering such care. Legal experts had warned that this approach could not lawfully bridge the statutory gap: agencies do not have authority to regulate the practice of medicine or to sidestep formal rulemaking steps. The court agreed, finding that process matters as much as policy in assessing legality.
Immediate effects on providers and patients
The announcement of the declaration produced swift consequences: many hospitals and health systems across the country reacted by pausing or limiting services for transgender youth, including puberty blockers and hormone therapy, out of concern for potential exclusion from federal programs or investigations. The court noted that exclusion from Medicare or Medicaid can be a financial death blow for providers that rely on federal reimbursements. Plaintiffs argued—and the court accepted—that the directive interfered with states’ authority to regulate health care and threatened access to treatments that state law and medical associations recognize as appropriate for some minors.
What the injunction accomplishes
By vacating the declaration and blocking its enforcement in the states that sued, the ruling restores the prior legal environment in those jurisdictions and allows clinicians to provide care without the specter of immediate federal sanction. The lawsuit was brought by a coalition led by Oregon and including California, New York, Washington, and other states that have protections for youth seeking gender-affirming care. The administration is expected to pursue appellate review, but for the moment the decision represents a significant setback for efforts to use administrative directives to curtail access to this category of treatment nationwide.
Responses and broader significance
Advocates and state officials welcomed the ruling. Leaders from organizations defending LGBTQ+ health care framed the decision as confirmation that the federal government cannot ignore procedural law in pursuit of a political agenda, and they credited state attorneys general for mounting the legal challenge. The judge framed the dispute as more than policy disagreement, finding that acting without proper authority and process causes real-world harms to families and providers. The opinion serves as a reminder that administrative action must be rooted in statutory authority and established rulemaking pathways when it seeks to reshape access to medical services.